Ideagen PLC Exercise of Options and Total Voting Rights (2233Y)
01 March 2017 - 10:47PM
UK Regulatory
TIDMIDEA
RNS Number : 2233Y
Ideagen PLC
01 March 2017
1 March 2017
Ideagen plc
("Ideagen" or the "Company")
Exercise of Options and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information
Management Software to highly regulated industries, announces that
it has allotted 25,000 new ordinary shares of 1 penny each in the
capital of the Company ("Ordinary Shares") following the exercise
of share options by an employee.
Application has been made to the London Stock Exchange for the
25,000 new Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 7 March
2017.
After Admission, the total number of Ordinary Shares in issue
will be 182,579,108 and the total number of voting rights will
therefore be 182,579,108. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
Enquiries:
Ideagen plc Tel: 01629 699100
David Hornsby, Chief Executive
Graeme Spenceley, Finance
Director
finnCap (Nominated Adviser Tel: 020 7220 0500
and Broker)
Stuart Andrews / Adrian
Hargrave / James Thompson
(Corporate Finance)
Stephen Norcross (Corporate
Broking)
About Ideagen plc
Ideagen is a UK company quoted on the London Stock Exchange AIM
market (Ticker: IDEA.L). Ideagen is a supplier of Information
Management software with operations in the UK, the United States
and the Middle East. The Company specialises in GRC (Governance,
Risk and Compliance) and Content and Clinical solutions with a
primary focus on organisations operating within highly regulated
industries. With an excellent portfolio of software products,
Ideagen is able to provide complete information lifecycle solutions
that enable organisations to reduce risk, meet their regulatory and
compliance standards, helping them to reduce costs and improve
efficiency.
The Group has a customer base of over 3,000 organisations using
the Ideagen suite of products, including many blue chip names such
as BAE Systems, Emirates, Shell and the European Central Bank as
well as 150 hospitals in the UK and US.
For further information please visit www.ideagen.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRLLFSLVSILIID
(END) Dow Jones Newswires
March 01, 2017 06:47 ET (11:47 GMT)
Ideagen (LSE:IDEA)
Historical Stock Chart
From Apr 2024 to May 2024
Ideagen (LSE:IDEA)
Historical Stock Chart
From May 2023 to May 2024